Idiopathic pulmonary fibrosis

Cancer Incidence in Five Continents

Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,378

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196

Fleischner Society: Glossary of Terms for Thoracic Imaging

Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Rémy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,189

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975

Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement

(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,651

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916

Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy

Ding, Y. F., Ding, Z., Xu, J., Li, Y., & Chen, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121469 · Cited by 15

Zinc Deficiency Induces Oxidative Damage and Causes Spleen Fibrosis

Zhang, Q., Zhang, H., Chen, Y., Wang, Y., Yang, M., & Guo, M. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01762-y · Cited by 15

An updated safety review of the drug treatments for idiopathic pulmonary fibrosis

Sgalla, G., Comes, A., & Richeldi, L. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1921143 · Cited by 16

miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach

Santos-Álvarez, J. C., Velázquez-Enríquez, J. M., García-Carrillo, R., Rodríguez-Beas, C., Ramírez-Hernández, A. A., Reyes-Jiménez, E., González-García, K., López-Martínez, A., Mayoral, L. P.-C., Aguilar-Ruíz, S. R., et al. (2022) · Cells · doi:10.3390/cells11071112 · Cited by 15

Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions

Vithalkar, M. P., Pradhan, S., Sandra, K., Byregowda, B. H., & Nayak, Y. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01696-4 · Cited by 14

MCTR1 Intervention Reverses Experimental Lung Fibrosis in Mice

Pan, J., Li, X., Wang, X., Yang, L., Chen, H., Su, N., Wu, C., Yu, H., Jin, S., & Li, H. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304811 · Cited by 14

Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis

Zhang, J., Zhong, W., Liu, Y., Chen, W., Lu, Y., Zeng, Z., Qiao, Y., Huang, H., Wan, X., Li, W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708462 · Cited by 14

A novel therapeutic approach for IPF: Based on the “Autophagy - Apoptosis” balance regulation of Zukamu Granules in alveolar macrophages

Li, S., Liu, G., Gu, M., Li, Y., Li, Y., Ji, Z., Li, K., Wang, Y., Zhai, H., & Wang, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115568 · Cited by 14

Ogerin mediated inhibition of TGF-β(1) induced myofibroblast differentiation is potentiated by acidic pH

Bell, T. J., Nagel, D. J., Woeller, C. F., & Kottmann, R. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271608 · Cited by 15

Cinnamaldehyde regulates mitochondrial quality against hydrogen peroxide induced apoptosis in mouse lung mesenchymal stem cells via the PINK1/Parkin signaling pathway

Ke, S., Zhu, W., Lan, Z., Zhang, Y., Mo, L., Zhu, G., & Liu, L. (2022) · PeerJ · doi:10.7717/peerj.14045 · Cited by 14

An Agent-Based Model of Radiation-Induced Lung Fibrosis

Cogno, N., Bauer, R., & Durante, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213920 · Cited by 13

Development and validation of the prognostic model based on autophagy-associated genes in idiopathic pulmonary fibrosis

Fan, G., Liu, J., Wu, Z. S., Li, C., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049361 · Cited by 15

Genistein alleviates pulmonary fibrosis by inactivating lung fibroblasts

Kwon, S., Chung, H., Seo, J.-W., & Kim, H. S. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0099 · Cited by 14

Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches

Shakeel, I., Afzal, M., Islam, A., Sohal, S. S., & Hassan, M. I. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100167 · Cited by 15

TRIOBP modulates β-catenin signaling by regulation of miR-29b in idiopathic pulmonary fibrosis

Wang, L., Zhao, W., Xia, C., Ma, S., Li, Z., Wang, N., Ding, L., Wang, Y., Cheng, L. C., Liu, H., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05080-4 · Cited by 15

Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6

Höhne, K., Wagenknecht, A., Maier, C., Engelhard, P., Goldmann, T., Schließmann, S. J., Plönes, T., Trepel, M., Eibel, H., Müller–Quernheim, J., et al. (2024) · Cells · doi:10.3390/cells13030238 · Cited by 13

Hypermethylation of PPARG-encoding gene promoter mediates fine particulate matter-induced pulmonary fibrosis by regulating the HMGB1/NLRP3 axis

Yang, S., Sun, Y., Luo, Y., Liu, Y., Jiang, M., Li, J., Zhang, Q., & Bai, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116068 · Cited by 14

Niclosamide - encapsulated lipid nanoparticles for the reversal of pulmonary fibrosis

Yu, Y., Liu, H., Yuan, L., Pan, M., Bei, Z., Ye, T., & Qian, Z. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100980 · Cited by 14

Dysregulated bidirectional epithelial–mesenchymal crosstalk: A core determinant of lung fibrosis progression

Yao, L., Xu, Z., Davies, D. E., Jones, M. G., & Wang, Y. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.02.001 · Cited by 14

Involvement of E3 ubiquitin ligase NEDD4-mediated YY1 ubiquitination in alleviating idiopathic pulmonary fibrosis

Chen, L., Sun, Q., Yue, R., Yan, H., Huang, X., Yu, H., & Yang, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131976 · Cited by 14

Aldehyde Dehydrogenase 2 Deficiency Aggravates Lung Fibrosis through Mitochondrial Dysfunction and Aging in Fibroblasts

Wei, Y., Gao, S., Li, C., Huang, X., Xie, B., Geng, J., Dai, H., & Wang, C. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.008 · Cited by 14

IPF-related new macrophage subpopulations and diagnostic biomarker identification - combine machine learning with single-cell analysis

Zhang, H., Yang, Y., Cao, Y., & Guan, J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02845-8 · Cited by 16

CX3C chemokine: Hallmarks of fibrosis and ageing

Chen, X., Yang, Y., Sun, S., Liu, Q., Yang, Y., & Jiang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107348 · Cited by 13

FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis

Ghanem, M., Archer, G., Justet, A., Jaillet, M., Vasarmidi, E., Mordant, P., Castier, Y., Mal, H., Cazes, A., Poté, N., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202311-2021oc · Cited by 16

Comprehensive analysis of lncRNA-associated competing endogenous RNA network and immune infiltration in idiopathic pulmonary fibrosis

Wang, Z., Qu, S., Zhu, J., Chen, F., & Ma, L. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-19-2842 · Cited by 14

Construction and validation of a bronchoalveolar lavage cell-associated gene signature for prognosis prediction in idiopathic pulmonary fibrosis

Xia, Y., Lei, C., Yang, D., & Luo, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107369 · Cited by 14

A phycocyanin derived eicosapeptide attenuates lung fibrosis development

Li, Q., Wen, P., Zhang, Z., Pei, X., Sun, Z., & Ou, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174356 · Cited by 15

Management of patients with fibrosing interstitial lung diseases

Morrow, L. E., Hilleman, D. E., & Malesker, M. A. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab375 · Cited by 14

Ghrelin attenuates transforming growth factor-β1-induced pulmonary fibrosis via the miR-125a-5p/Kruppel-like factor 13 axis

Qiu, J. Y., Ma, C., Dai, W., Fang, E., Li, W., & Yang, F. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109082 · Cited by 14

Salt-inducible kinase 2 (SIK2) inhibitor ARN-3236 attenuates bleomycin-induced pulmonary fibrosis in mice

Zou, L., Hong, D., Li, K., & Jiang, B. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01940-0 · Cited by 14

Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway

Miao, Y., Li, X., Yang, Y., Zhang, J., Chen, L., Zhang, Q., Li, W., Liu, Y., Zhang, X., Gu, R., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109427 · Cited by 14

Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis

Santos‐Ribeiro, D., Lecocq, M., Beukelaer, M. D., Verleden, S. E., Bouzin, C., Ambroise, J., Dorfmüller, P., Yakoub, Y., Huaux, F., Quarck, R. A., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0541oc · Cited by 15

Magnetic Resonance Elastography (MRE) of Bleomycin-Induced Pulmonary Fibrosis in an Animal Model

Fakhouri, F. S., Joseph, M., Ballinger, M. N., Shukla, V. C., Weimar, D., Novak, C. M., Ghadiali, S. N., & Kolipaka, A. (2022) · Investigative Radiology · doi:10.1097/rli.0000000000000935 · Cited by 14

Dissecting lung development and fibrosis at single-cell resolution

Färber, D. L., & Sims, P. A. (2019) · Genome Medicine · doi:10.1186/s13073-019-0645-7 · Cited by 14

Epithelial stem cells from human small bronchi offer a potential for therapy of idiopathic pulmonary fibrosis

Liu, Z., Zheng, Q., Li, Z., Huang, M., Zhong, C., Yu, R., Jiang, R., Dai, H., Zhang, J., Gu, X., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2024.105538 · Cited by 15

Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases

Perryman, L., & Gray, S. G. (2022) · Cancers · doi:10.3390/cancers14040981 · Cited by 13

Diterpenoid alkaloids isolated from Delphinium trichophorum alleviate pulmonary fibrosis via the TGF-β/Smad pathway in 3T6 and HFL-1 cells

Yao, Y., Chen, Y., Zeren, D., Ma, Y., Xie, Y., Wang, Q., Ma, H., Wang, M., Liu, F., Zhu, C., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112906 · Cited by 13

Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome

Gao, A. Y., Espinosa, A. M. D., Gianì, F., Pham, T. X., Carver, C. M., Aravamudhan, A., Bartman, C. M., Ligresti, G., Caporarello, N., Schafer, M. J., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00023.2022 · Cited by 14

Artificial neural network identified the significant genes to distinguish Idiopathic pulmonary fibrosis

Li, Z., Wang, S., Zhao, H., Yan, P., Yuan, H., Zhao, M., Wan, R., Yu, G., & Wang, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-28536-w · Cited by 13

Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts

Gao, A. Y., Espinosa, A. M. D., Nguyen, B. B. N., Link, P. A., Meridew, J. A., Jones, D. L., Gibbard, D. F., Tschumperlin, D. J., & Haak, A. J. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001442 · Cited by 13

Intermittent hypoxia exacerbated depressive and anxiety-like behaviors in the bleomycin-induced pulmonary fibrosis mice

Xiong, M., Wu, Z., Zhao, Y., Zhao, D. B., Pan, Z., Wu, X., Liu, W. Q., & Hu, K. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.04.008 · Cited by 13

Dickkopf1 Promotes Pulmonary Fibrosis upon Bleomycin-Induced Lung Injury

Sung, E., Park, M. H., Henegariu, O., Sime, P. J., & Chae, W. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.05.009 · Cited by 13

Vincamine as an agonist of G protein-coupled receptor 40 effectively ameliorates pulmonary fibrosis in mice

Zhao, T., Zhou, Z., Zhao, S., Wan, H., Li, H., Hou, J., Wang, J., Qian, M., & Shen, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154919 · Cited by 13

Soluble E‐cadherin participates in BLM ‐induced pulmonary fibrosis by promoting EMT and lung fibroblast migration

Huang, C., Liang, C., Tong, J., Zhong, X., Luo, L., Liang, L.-P., Wen, Y., Zhong, L., Deng, J., Peng, M., et al. (2023) · Environmental Toxicology · doi:10.1002/tox.23986 · Cited by 13

Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis

Huang, W., Chuang, C.-F., Huang, Y.-T., Chung, I., Chen, M.-L., Chuang, T., Yang, X., Chou, Y.-Y., Liu, C.-H., Chen, N., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02583-3 · Cited by 15

High matrix stiffness promotes senescence of type II alveolar epithelial cells by lysosomal degradation of lamin A/C in pulmonary fibrosis

Ba, J., Zheng, C., Lai, Y., He, X., Pan, Y., Zhao, Y., Xie, H., Wu, B., Deng, X., & Wang, N. (2025) · Respiratory Research · doi:10.1186/s12931-025-03201-0 · Cited by 13

Biomarkers and their potential functions in idiopathic pulmonary fibrosis

Ni, S., Song, M. S., Guo, W., Guo, T., Shen, Q., & Peng, H. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1745066 · Cited by 13

Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities

Cruwys, S., Hein, P., Humphries, B., & Black, D. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.019 · Cited by 14

Feasibility and Mechanism Analysis of Shenfu Injection in the Treatment of Idiopathic Pulmonary Fibrosis

Liu, P., Yang, S., Wang, Z., Dai, H., & Wang, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670146 · Cited by 13

Characteristics of COVID-19 Pneumonia Survivors With Resting Normoxemia and Exercise-Induced Desaturation

Vitacca, M., Paneroni, M., Brunetti, G., Carlucci, A., Balbi, B., Spanevello, A., & Ambrosino, N. (2021) · Respiratory Care · doi:10.4187/respcare.09029 · Cited by 13

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia

Hashimoto, S., Iwata, H., Hattori, Y., Nakajima, K., Nomura, K., Hayashi, K., Toshito, T., Yamamori, E., Akita, K., Mizoe, J., et al. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02027-0 · Cited by 13

Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry

Nagy, T., Tóth, N. M., Palmer, E., Polivka, L., Csoma, B., Nagy, A., Eszes, N., Vincze, K., Bárczi, E., Bohács, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092129 · Cited by 13

Fatty acid metabolism-related genes in bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis

Lyu, Y., Chen, G., & Zhang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1001563 · Cited by 13

Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis

Piotrowski, W. J., Martusewicz-Boros, M. M., Białas, A. J., Barczyk, A., Batko, B. P., Błasińska, K., Boros, P. W., Górska, K., Grzanka, P., Jassem, E., et al. (2022) · Advances in respiratory medicine · doi:10.3390/arm90050052 · Cited by 13

The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-β production in regulatory T-cells

Kagawa, K., Sato, S., Koyama, K., Imakura, T., Murakami, K., Yamashita, Y., Naito, N., Ogawa, H., Kawano, H., & Nishioka, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275987 · Cited by 14

Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis

Su, X., Tan, Z., Wang, G., Liu, Z., Gan, C., Yue, L., Liu, H., Xie, Y., Yao, Y., & Ye, T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114918 · Cited by 13

Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity

Lu, Y., Tang, K., Wang, S., Tian, Z., Fan, Y., Li, B., Wang, M., Zhao, J., & Xie, J. (2023) · Translational research · doi:10.1016/j.trsl.2023.01.006 · Cited by 13

Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-β1/Smad2/3 pathway

Jiao, H., Li, S., & Tang, Q. (2023) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2023.102230 · Cited by 13

Antithrombin III as predictive indicator of survival in idiopathic pulmonary fibrosis (IPF) patients treated with nintedanib: a preliminary study

Bergantini, L., d’Alessandro, M., Cameli, P., Carleo, A., Landi, C., Vietri, L., Lanzarone, N., Pieroni, M., Sestini, P., & Bargagli, E. (2020) · Internal Medicine Journal · doi:10.1111/imj.14768 · Cited by 13

Traditional Chinese medicine for the treatment of pulmonary fibrosis

Li, L., Chen, X., Yang, W.-N., Xu, X., Lu, L., Wang, J., Kong, Y., & Zheng, J. (2020) · Medicine · doi:10.1097/md.0000000000021310 · Cited by 13

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids

Brereton, C. J., & Jo, H. E. (2020) · Breathe · doi:10.1183/20734735.0086-2020 · Cited by 13

Microbiota and IPF: hidden and detected relationships.

Fabbrizzi, A., Nannini, G., Lavorini, F., Tomassetti, S., & Amedei, A. (2021) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v38i3.11365 · Cited by 14

Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis

Nishioka, Y., Homma, S., Ogura, T., Sato, S., Arai, N., Tomii, K., Kamio, K., Sakamoto, S., Miyazaki, Y., Tomioka, H., et al. (2023) · Respiratory Investigation · doi:10.1016/j.resinv.2023.04.008 · Cited by 12

Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Pathogenesis, Biomarkers and Innovative Therapeutic Strategies

Yang, Y., Lv, M., Xu, Q., Wang, X., & Fang, Z.-J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s491335 · Cited by 14

Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions

Cao, X., Xia, C., Li, C., Deng, S., Cao, J., Yang, H., Wang, S., & Chen, P. (2026) · MedComm · doi:10.1002/mco2.70603 · Cited by 13

Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway

Chen, S., Wei, Y., Li, S., Miao, Y., Gu, J., Cui, Y., Liu, Z., Liang, J., Wei, L., Li, X., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109316 · Cited by 12

The roles of long noncoding RNA-mediated macrophage polarization in respiratory diseases

Qiao, X., Ding, Y., Wu, D., Zhang, A., Yin, Y., Wang, Q., Wang, W. T., & Kang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1110774 · Cited by 12

Preparation and evaluation of sustained release pirfenidone-loaded microsphere dry powder inhalation for treatment of idiopathic pulmonary fibrosis

Bao, S., Zou, Y., Firempong, C. K., Feng, Y., Yang, Y. L., Wang, Y., Dai, H., Mo, W., Sun, C., & Liu, H. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106509 · Cited by 12

Characterizing the lavage and serum cytokine profiles of interstitial pneumonia with autoimmune features and their implications for progressive fibrosis

Zhang, Z., Ma, X., Bai, J., Xia, S., Han, Q., & Luo, Q. (2023) · Rheumatology · doi:10.1093/rheumatology/kead409 · Cited by 12

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment

Luo, Y.-L., Li, Y., Zhou, W., Wang, S., & Liu, Y. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s415453 · Cited by 12

A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis

Jing, C., Fu, R., Liu, X., Zang, G., Zhu, X. L., Wang, C., & Zhang, W. Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1268141 · Cited by 12

Alpinetin ameliorates bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation

Chen, H., Liu, C., Zhan, Y., Wang, Y., Hu, Q., & Zeng, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116101 · Cited by 13

Pterostilbene: a potential therapeutic agent for fibrotic diseases

Wang, W., Li, K., Bai, D., Wu, J., & Xiao, W. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01440-z · Cited by 12

Wogonin protects against bleomycin-induced mouse pulmonary fibrosis via the inhibition of CDK9/p53-mediated cell senescence

Wang, L., Lin, F., Liu, Y., Li, W., Ding, Q., Duan, X., Yang, L., Bai, Z., Zhang, M., & Guo, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407891 · Cited by 13

Suppression of OGN in lung myofibroblasts attenuates pulmonary fibrosis by inhibiting integrin αv-mediated TGF-β/Smad pathway activation

Huang, S., Lin, Y., Deng, Q., Zhang, Y., Peng, S., Qiu, Y., Huang, W., Wang, Z., & Lai, X. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.07.001 · Cited by 14

Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress

Zhang, Y., Zhou, L., Cheng, G., Zhou, Y., Guo, Q., Wu, J., Wong, Y. K., Zhang, J., Tang, H., & Wang, J. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.91 · Cited by 12

Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis

Cheng, H., Jiang, S.-H., Cai, J., Luo, Z., Li, X., & Feng, D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1426508 · Cited by 15

Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways

Yin, J.-B., Wang, Y., Fan, S.-S., Shang, W.-B., Zhu, Y.-S., Peng, X., Zou, C., & Zhang, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309833 · Cited by 12

Emerging roles of noncoding RNAs in idiopathic pulmonary fibrosis

Wang, H., Sun, K., Peng, H. F., Wang, Y., & Zhang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02170-5 · Cited by 14

Mesenchymal Stem Extracellular Vesicles in Various Respiratory Diseases: A New Opportunity

Hu, Z., Zhu, L., Zhu, Y., & Xu, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s480345 · Cited by 12

Deciphering the cellular and molecular landscape of pulmonary fibrosis through single-cell sequencing and machine learning

Zhou, Y., Tong, Z., Zhu, X., Wu, C., Zhou, Y., & Dong, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06031-8 · Cited by 14

A micro-lung chip with macrophages for targeted anti-fibrotic therapy

Xia, J., Dong, R., Fang, Y., Guo, J., Xiong, Z., Zhang, T., & Sun, W. (2025) · Biofabrication · doi:10.1088/1758-5090/adb338 · Cited by 13

Rosa roxburghii Fermentation Broths Attenuate Bleomycin‐Induced Pulmonary Fibrosis by Activating the Nrf2/ HO ‐1/ NQO1 Signaling Pathway and Modulating Gut Microbiota

Zhou, H., Zheng, X., Huang, S., Wang, X., Zhou, T. J., Zhang, S., Ling, Y., Wang, W., Li, X., Li, S., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70105 · Cited by 12

Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts

Stojanović, S. D., Fuchs, M., Fiedler, J., Xiao, K., Meinecke, A., Just, A., Pich, A., Thum, T., & Kunz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114126 · Cited by 13

Allogeneic and Autologous Telomerase-Positive Stem Cells as a Potential Treatment for Systemic Lupus Erythematosus

Young, W., & Speight, M. O. (2020) · Stem Cell & Regenerative Medicine · doi:10.33425/2639-9512.1054 · Cited by 12

Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Wen-Yu-Jin against Pulmonary Fibrosis in a Mouse Model

Wang, L., Zhu, W., Sun, R., Liu, J., Ma, Q., Zhang, B., & Shi, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7753508 · Cited by 10

Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis

Pitre, T., Khalid, M. F., Cui, S., Zhang, M. C., Husnudinov, R., Mah, J. C., Helmeczi, W., Su, J. S., Banfield, L., Guy, B., et al. (2022) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2022.102128 · Cited by 12

Role of transient receptor potential vanilloid 4 in therapeutic antifibrotic effects of pirfenidone

Kuronuma, K., Otsuka, M., Wakabayashi, M., Yoshioka, T., Kobayashi, T., Kameda, M., Morioka, Y., Chiba, H., & Takahashi, H. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00565.2020 · Cited by 12

miR-155-5p/FOXO3a promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome activation

Wu, L., Li, P., & Zhuang, Z. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2115923 · Cited by 14

Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis

Wang, E., Wang, Y., Zhou, S., Xia, X., Han, R., Fei, G., Zeng, D., & Wang, R. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.73305 · Cited by 11

Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis

Fu, C., Chen, L., Cheng, Y., Yang, W., Zhu, H., Wu, X., & Cai, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1114601 · Cited by 12

Inhibitory Effects of 3-Cyclopropylmethoxy-4-(difluoromethoxy) Benzoic Acid on TGF-β1-Induced Epithelial–Mesenchymal Transformation of In Vitro and Bleomycin-Induced Pulmonary Fibrosis In Vivo

Sun, T., Li, H., Zhang, Y., Xiong, G., Liang, Y., Lü, F., Zheng, R., Zou, Q., & Hao, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076172 · Cited by 12

Betulin and Crinum asiaticum L. bulbs extract attenuate pulmonary fibrosis by down regulating pro-fibrotic and pro-inflammatory cytokines in bleomycin-induced fibrosis mice model

Ofori, M., Danquah, C. A., Asante, J., Ativui, S., Doe, P., Taribabu, A. A.-N., Nugbemado, I. N., & Mensah, A. N. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16914 · Cited by 13

Effect of valacyclovir on EHV-5 viral kinetics in horses with equine multinodular pulmonary fibrosis

Easton‐Jones, C. A., Madigan, J. E., Barnum, S. M., Maxwell, L. K., Taylor, S. D., Arnesen, T., & Pusterla, N. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15230 · Cited by 14

Bufei Decoction Alleviated Bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice by Anti‐Inflammation

Yang, S., Cui, W., Wang, M., Xing, L., Wang, Y., Zhu, P., Qu, Q., & Tang, Q. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/7483278 · Cited by 12

Pterostilbene alleviates pulmonary fibrosis by regulating ASIC2

Peng, Y., Zhang, Y., Zhang, Y., Wang, X., Xia, Y., Ye, T., Wu, Z., & Ke, H. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00474-7 · Cited by 12

Chromatin Landscapes of Human Lung Cells Predict Potentially Functional Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Variants

Benway, C. J., Liu, J., Guo, F., Du, F., Randell, S. H., Cho, M. H., Silverman, E. K., & Zhou, X. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0475oc · Cited by 12

Downregulation of miR‑483‑5p inhibits TGF‑β1‑induced EMT by targeting RhoGDI1 in pulmonary fibrosis

Huang, G., Zhang, J., Qing, G., Liu, D., Wang, X., Chen, Y., Wu, Y., Li, Y., & Guo, S. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12177 · Cited by 12

Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice

Yuan, Y., Li, Y., Qiao, G., Zhou, Y., Xu, Z., Hill, C. N., Jiang, Z., & Wang, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.675437 · Cited by 12

Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway

Li, Y., Wang, L., Zhang, Q., Li, T., Gan, C., Liu, H., Yin, W., & Ye, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.825915 · Cited by 13

Pronostic et exacerbations aiguës de la fibrose pulmonaire idiopathique

Uzunhan, Y. (2010) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(10)70127-0

Idiopathic Pulmonary Fibrosis: An Overview

May, J., & Jenkins, G. R. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm50844 · Cited by 1

New Aspects of Idiopathic Pulmonary Fibrosis

Molina‐Molina, M., Vicens, V., & Estany, S. (2010) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0b013e3181e4bb22 · Cited by 1

Re-dimensioning the treatment paradigm in idiopathic pulmonary fibrosis

Richeldi, L. (2018) · Monografías de Archivos de Bronconeumología

Idiopathic pulmonary fibrosis and progressive fibrotic interstitial lung disease

Evans, P., Rowlands, E., & Hope‐Gill, B. (2023) · Medicine · doi:10.1016/j.mpmed.2023.09.001 · Cited by 3